[Informe de investigación] Se espera que el mercado de sistemas de procesamiento de tejidos alcance los 493,76 millones de dólares en 2027, desde los 335,78 millones de dólares de 2019; Se estima que el mercado crecerá a una tasa compuesta anual del 5,1 % entre 2020 y 2027.
El procesamiento de tejidos es un paso entre la fijación e inclusión de tejidos y la sección de bloques de parafina. La técnica se utiliza en la preparación de tejidos para análisis microscópico poniéndolos en un medio sólido. El procesamiento de tejidos ayuda a proporcionar cortes muy finos y de alta calidad montados en portaobjetos de vidrio y teñidos adecuadamente para indicar estructuras normales y anormales. El crecimiento del mercado mundial de sistemas de procesamiento de tejidos se atribuye principalmente a factores como la creciente prevalencia del cáncer y el creciente número de diagnósticos. laboratorios. Sin embargo, el alto costo del diagnóstico del cáncer está restringiendo el crecimiento del mercado.
Mercados regionales lucrativos para sistemas de procesamiento de tejidos
Perspectivas del mercado
Aumento de la prevalencia del cáncer
Los sistemas de procesamiento de tejidos se utilizan ampliamente en los laboratorios de diagnóstico del cáncer. Las muestras de biopsia se procesan en procesadores de tejidos para el diagnóstico de cáncer. Los procesadores de tejidos están ampliamente disponibles desde la década de 1940 y son fáciles de usar y manejar. Pueden gestionar una gran cantidad de muestras, procesarlas rápidamente y producir resultados de alta calidad.
Según la Organización Mundial de la Salud (OMS), el cáncer es la segunda causa de muerte en todo el mundo; En 2018, la enfermedad causó 9,6 millones de muertes en todo el mundo. Además, aproximadamente una de cada seis muertes se debe al cáncer en todo el mundo. Es probable que el aumento del número de casos de cáncer en Europa y la infraestructura de diagnóstico avanzada en Europa favorezcan el crecimiento del mercado en Europa. Por ejemplo, el Centro Común de Investigación publicó estimaciones de 2020 sobre la prevalencia del cáncer en la Unión Europea en julio de 2020. Estimó que la carga del cáncer aumentó a 2,7 millones de casos nuevos y 1,3 millones de muertes en 2020.
Por lo tanto, la prevalencia aumenta del cáncer aumenta la demanda de procesadores de tejidos en el diagnóstico.
Información basada en productos
El mercado de sistemas de procesamiento de tejidos, por producto, se segmenta en procesadores de transferencia de tejidos y procesadores de transferencia de fluidos. El segmento de procesadores de transferencia de fluidos tuvo una mayor participación del mercado en 2019, mientras que se prevé que el segmento de procesadores de transferencia de tejidos registre una CAGR más alta en el mercado durante el período de pronóstico. Los procesadores de transferencia de tejidos confieren flexibilidad en el uso de reactivos y permiten a los usuarios ejecutar diferentes programas con ellos.
Mercado de sistemas de procesamiento de tejidos, por producto: 2019 y 2027
Información basada en volumen
El mercado de sistemas de procesamiento de tejidos, por volumen, está segmentado en procesadores de pequeño volumen, procesadores de mediano volumen y procesadores de gran volumen. El segmento de procesadores de pequeño volumen tuvo la mayor participación del mercado en 2019, y se prevé que el segmento de procesadores de volumen mediano registre la CAGR más alta durante el período de pronóstico.
Fin Información basada en el usuario
Según el usuario final, el mercado de sistemas de procesamiento de tejidos se segmenta en hospitales, empresas farmacéuticas, laboratorios de investigación y otros. El segmento de hospitales tuvo la mayor participación de mercado en 2019, mientras que se estima que el segmento de compañías farmacéuticas registrará la CAGR más alta del 5,7% durante el período previsto.
Estratégico Insights
Los lanzamientos y aprobaciones de productos son las estrategias comúnmente adoptadas por las empresas para expandir su presencia global y sus carteras de productos. La colaboración es una de las principales estrategias adoptadas por los actores del mercado de sistemas de procesamiento de tejidos para ampliar la base de clientes en todo el mundo, lo que también les permite mantener su marca a nivel mundial.
Procesamiento de tejidos Mercado de sistemas: por producto
- Procesadores de transferencia de tejidos
- Procesadores de transferencia de fluidos
Mercado de sistemas de procesamiento de tejidos: por Volumen
- Procesadores de Pequeño Volumen
- Procesadores de Volumen Medio
- Procesadores de Gran Volumen
Pañuelos Mercado de sistemas de procesamiento: por Usuario Final
- Hospitales
- Empresas Farmacéuticas
- Laboratorios de Investigación
- Otros
Mercado de sistemas de procesamiento de tejidos: por Geografía
- América del Norte
- Estados Unidos
- Canadá
- México
< li>Europa - Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico (APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Resto de Asia Pacífico
- Medio Oriente y África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de MEA
- América del Sur y Central< ul>
- Brasil
- Argentina
- Resto de América del Sur y Central
Perfiles de la empresa
- MiltenyiBiotec
- BioGenex
- Leica Biosystems Nussloch GmbH (Danaher)
- Avantor, Inc.
- THERMO FISHER SCIENTIFIC INC.
- Siemens AG
- F. HOFFMANN-LA ROCHE LTD.
- Agilent Technologies, Inc.
- Milestone Medical
- Sakura Finetek USA, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Tissue processing occurs between tissue fixation and the embedding as well as the sectioning of the paraffin blocks. Tissue processing is used in the preparation of the tissue for microscopic analysis by putting the tissue in a solid medium. Tissue processing helps to provide very thin and high-quality slices mounted on the glass slides and properly stained to indicate normal and abnormal structures.
The factors that are driving growth of the market are increasing prevalence of cancer and rising number of diagnostic laboratories are factors driving the market growth. However, high cost of cancer diagnosis may hinder the market growth.
The tissue processing systems market majorly consists of the players such as Agilent Technologies, Inc., Biogenex Laboratories, Sakura Finetek Usa, Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Siemens Ag, Avantor, Milestone Medical, Leica Biosystems (Danaher Corporation), Miltenyi Biotec amongst others.
The List of Companies - Tissue Processing Systems Market
- Agilent Technologies Inc.
- Biogenex Laboratories
- Sakura Finetek Usa Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche AG
- Siemens Ag
- Avantor
- Milestone Medical
- Leica Biosystems (Danaher Corporation)
- Miltenyi Biotec
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Dec 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Dec 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Dec 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Dec 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)